SELB Insider Trading Activity and SEC Form 4 Filings
SELB insider trading summary
No open-market insider purchases or sales of Selecta Biosciences Inc (SELB) have been reported on SEC Form 4 in the past 12 months.
Latest SELB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2023 | Peter G Traber | Chief Medical Officer | Sell | $747 (705 @ $1.06) |
| Sep 25, 2023 | Carsten Brunn | President and CEO | Sell | $3K (2,932 @ $1.06) |
| Jan 5, 2023 | Takashi Kei Kishimoto | Chief Scientific Officer | Sell | $4K (3,372 @ $1.13) |
| Jan 5, 2023 | Takashi Kei Kishimoto | Chief Scientific Officer | Sell | $22 (20 @ $1.11) |
| Jan 5, 2023 | Peter G Traber | Chief Medical Officer | Sell | $4K (3,445 @ $1.13) |
| Jan 5, 2023 | Carsten Brunn | President and CEO | Sell | $15K (13,396 @ $1.13) |
| Jan 5, 2023 | Lloyd P. Johnston | Chief Operations Officer | Sell | $22 (20 @ $1.11) |
| Jan 5, 2023 | Lloyd P. Johnston | Chief Operations Officer | Sell | $4K (3,372 @ $1.13) |
| Jan 5, 2023 | Peter G Traber | Chief Medical Officer | Sell | $22 (20 @ $1.11) |
| Jan 5, 2023 | Carsten Brunn | President and CEO | Sell | $86 (77 @ $1.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.